Chemours (CC) Gains from Investment Securities (2014 - 2026)

Chemours' Gains from Investment Securities history runs 13 years deep, the most recent figure standing at $4.3 million for Q1 2026.

• In Q1 2026, Gains from Investment Securities fell 17.46% year-over-year to $4.3 million; the TTM figure through Mar 2026 stood at $4.3 million (down 17.46% YoY), while the FY2025 annual figure was $6.1 million, up 767.23% from the prior year.
• Gains from Investment Securities was $4.3 million for Q1 2026 at Chemours, up from $933000.0 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $100.0 million in Q4 2024 to a low of -$9.0 million in Q4 2023.
• Historically, Gains from Investment Securities has averaged $13.8 million across 5 years, with a median of $2.0 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Gains from Investment Securities tumbled 110.34% in 2023, then soared 1211.11% in 2024.
• A 5-year view of Gains from Investment Securities shows it stood at $87.0 million in 2022, then sank by 110.34% to -$9.0 million in 2023, then jumped by 1211.11% to $100.0 million in 2024, then tumbled by 99.07% to $933000.0 in 2025, then soared by 356.85% to $4.3 million in 2026.
• The last three Gains from Investment Securities figures came in at $4.3 million (Q1 2026), $933000.0 (Q3 2025), and $929000.0 (Q2 2025), per Business Quant data.